Arbutus Biopharma
ABUS
ABUS
80 hedge funds and large institutions have $79.4M invested in Arbutus Biopharma in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 12 closing their positions.
Holders
80
Holders Change
+15
Holders Change %
+23.08%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
22
Reduced
12
Closed
12
Calls
$4.67M
Puts
$6.87M
Net Calls
-$2.2M
Net Calls Change
-$1.83M
Top Buyers
1 |
1
BlackRock
New York
|
$6.47M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$9.76M |
3 |
3
Renaissance Technologies
New York
|
$1.56M |
4 |
4
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$1.36M |
5 |
![]()
5
Group One Trading
Chicago,
Illinois
|
$1.17M |